Ex Parte PerkinsDownload PDFBoard of Patent Appeals and InterferencesMar 2, 201211017586 - (D) (B.P.A.I. Mar. 2, 2012) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES __________ Ex parte JAMES T. PERKINS __________ Appeal 2010-009601 Application 11/017,586 Technology Center 3700 __________ Before DEMETRA J. MILLS, ERIC GRIMES, and FRANCISCO C. PRATS, Administrative Patent Judges. MILLS, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134. The Examiner has rejected the claims as anticipated and obvious. We have jurisdiction under 35 U.S.C. § 6(b). Appeal 2010-009601 Application 11/017,586 2 STATEMENT OF THE CASE The following claim is representative: 1. An ophthalmic phacoemulsification irrigation sleeve comprising: an elongated resilient essentially tubular body portion having a distal end and a proximal end for surrounding a portion of a shaft of a phacoemulsification needle; an enlarged section formed on the proximal end of the body portion for surrounding a hub of a needle and for connection to a phacoemulsification handpiece; and wherein adjacent to the tubular body portion distal end at least one noncircular irrigation port is formed such that a shape of the port includes a radiused leading edge closest to the distal end and has tapering trailing sides resulting in a trailing end having a smaller radius than the leading edge radius. Cited References The Examiner relies on the following prior art references: Lindsay et al. US 4,863,441 Sep. 5, 1989 O‟Neill et al. US 5,324,260 Jun. 28, 1994 Mackool US 7,014,629 B2 Mar. 21, 2006 Strukel US 5,919,157 Jul. 6, 1999 Grounds of Rejection Claim 1 is rejected under 35 U.S.C.§ 102(b) over Lindsay. Claim 2 is rejected under 35 U.S.C. §103(a) over Lindsay in view of O‟Neill. Claims 1 and 3 are rejected under 35 U.S.C. § 103(a) over Mackool in view of Lindsay. Claim 2 is rejected under 35 U.S.C. § 103(a) over Mackool, in view of Lindsay and Strukel. Appeal 2010-009601 Application 11/017,586 3 FINDINGS OF FACT The Examiner‟s findings of fact are set forth in the Answer at pages 3- 11. The following fact is highlighted. 1. Lindsay, figure 2 is reproduced below. Lindsay, Figure 2 shows a venous return catheter with transitional areas 20 and 16 including inlet opening 24. Discussion ISSUE The Examiner concludes that the phacoemulsion needle and phaco handpiece are not structural requirements of the pending claims. The Examiner argues that the structural requirements of the preamble of the claim include a tubular structure capable of irrigation in a medical environment. (See Ans. 4.) The Examiner argues that the claims are “not limited to the human eye” and do not require an open distal end. (Id. at 10.) Structurally, the Examiner argues that the device of Lindsay discloses non- circular irrigation ports that are “adjacent” to the distal portion of the device. (Id.) Appeal 2010-009601 Application 11/017,586 4 Appellant argues that the preamble of the claims “expressly limits the claims to a phacoemulsification (phaco) irrigation sleeve - that is a sleeve for surrounding a phaco needle that will deliver (infuse) fluid into the eye” and that the Examiner has ignored this claimed feature. (App. Br. 3; Reply Br. 2.) Appellant further argues that the Specification‟s field of invention supports this claim interpretation. (Reply Br. 2.) Appellant argues that Lindsay‟s device “cannot properly function as a phaco sleeve,” and that Lindsay‟s “openings 24 are not adjacent to the distal end” of the device (App. Br. 6 and 7.) The issues are: Is the claim preamble given weight with respect to claim interpretation? Does the cited prior art support the Examiner‟s conclusion that the device of Lindsay is capable of functioning as a phacoemulsion sleeve with openings adjacent to the distal end of the device? PRINCIPLES OF LAW In order for a prior art reference to serve as an anticipatory reference, it must disclose every limitation of the claimed invention, either explicitly or inherently. See In re Schreiber, 128 F.3d 1473, 1477 (Fed. Cir. 1997). To anticipate, every element and limitation of the claimed invention must be found in a single prior art reference, arranged as in the claim. Karsten Mfg. Corp. v. Cleveland Golf Co., 242 F.3d 1376, 1383 (Fed. Cir. 2001). “In rejecting claims under 35 U.S.C. § 103, the examiner bears the initial burden of presenting a prima facie case of obviousness. Only if that burden is met, does the burden of coming forward with evidence or argument shift to the applicant.” In re Rijckaert, 9 F.3d 1531, 1532 (Fed. Cir. 1993) (citations omitted). In order to determine whether a prima facie Appeal 2010-009601 Application 11/017,586 5 case of obviousness has been established, we consider the factors set forth in Graham v. John Deere Co., 383 U.S. 1, 17 (1966): (1) the scope and content of the prior art; (2) the differences between the prior art and the claims at issue; (3) the level of ordinary skill in the relevant art; and (4) objective evidence of nonobviousness, if present. “If the claim preamble, when read in the context of the entire claim, recites limitations of the claim, or, if the claim preamble is „necessary to give life, meaning, and vitality‟ to the claim, then the claim preamble should be construed as if in the balance of the claim. . . . If, however, the body of the claim fully and intrinsically sets forth the complete invention, including all of its limitations, and the preamble offers no distinct definition of any of the claimed invention‟s limitations, but rather merely states, for example, the purpose or intended use of the invention, then the preamble is of no significance to claim construction because it cannot be said to constitute or explain a claim limitation.” Pitney Bowes Inc. v. Hewlett Packard Co., 182 F.3d 1298, 1305 (Fed. Cir. 1999). ANALYSIS While we agree with the Examiner that the phacoemulsification needle and phaco handpiece are not structural requirements of the pending claims and that the claims are not limited to the human eye and do not require an open distal end, contrary to the Examiner, we find that the preamble of the claimed subject matter, a phacoemulsification irrigation sleeve, informs the capabilities of the structure of the claimed device. Appeal 2010-009601 Application 11/017,586 6 We further agree with Appellant that Lindsay does not disclose non- circular irrigation ports at the distal end of the tubular body, as claimed. As Appellant argues, ports 24 of Lindsay, in transitional area 20, lie outside the vena cava and second catheter portion 16 cannot enter the vena cava if appropriately dimensioned. (See Lindsay col. 3, l. 26, App. Br. 6.) For this reason, Appellant argues that the device of Lindsay could not function as a phacoemulsification irrigation sleeve, and that the “openings 24 would deliver fluid outside of the eye and fluid would spill all over the patient and the eye would collapse without a steady supply of irrigation fluid and cause serious damage to the eye.” (App. Br. 7.) In contrast, the Examiner points to no evidence suggesting that a device of Lindsay‟s size would be capable functioning as a phacoemulsification sleeve. Thus we find that a preponderance of the evidence of record does not support the Examiner‟s position that the device of Lindsay is capable of functioning as a phacoemulsification irrigation device, and that Lindsay‟s openings 24 are not adjacent to the distal end of the device, as claimed. The anticipation rejection of claim 1 is reversed. The Examiner has not adequately explained why the limitations not taught by Lindsay would nevertheless have been obvious. For this reason, the obviousness rejection of claim 2 is reversed. Similarly, Examiner has not adequately explained why the port 24 of Lindsay would have made obvious the limitations not taught by Mackool, and these obviousness rejections are also reversed. Appeal 2010-009601 Application 11/017,586 7 CONCLUSION OF LAW The cited references do not support the Examiner‟s anticipation and obviousness rejections. The rejections are reversed. REVERSED alw Copy with citationCopy as parenthetical citation